Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-Label Clobazam for Lennox-Gastaut Syndrome
NCT01160770Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Dec 2005
- Primary completion
- Feb 2012
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of clobazam in Lennox-Gastaut syndrome (LGS), sponsored by Lundbeck. Started Dec 2005; status: completed.
02
Drugs
clobazam
03
Conditions
Lennox-Gastaut syndrome (LGS)
Beyond the preview
Go deeper on NCT01160770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01160770.